Melya Hughes Crameri is a seasoned executive and life science entrepreneur with over 25 years’ experience in the biotech and pharmaceutical industry. She has founded and served as CEO, CXO and at board level for companies in Europe as well as in the United States. She has negotiated more than USD 80M in government contracts and secured USD150M+ for life sciences companies, has been responsible for a number of high value partnering deals, as well as preparing companies for listing on the SIX stock exchange. Melya joined Ventac Partners in 2015 as the founding partner of its London office. She has also served on boards and committees for life sciences industry cluster building and innovation uptake by the healthcare system.